Lilly pill keeps weight off after injectable drugs in trial
New data shows Eli Lilly's oral weight-loss drug successfully maintains weight reduction after patients switch from injectable medications. A breakthrough for chronic obesity management.
Category : Search result: normal weight obesity
Bob Odenkirk's 'Normal' Filmed in Manitoba Hits Theatres
The crime thriller 'Normal,' starring Bob Odenkirk and filmed in Manitoba, is now in theatres. Discover the local connection and film details.
Weight Watchers Unveils New Platform for GLP-1 Era
Weight Watchers launches a fully integrated digital platform offering comprehensive support for members using GLP-1 medications, featuring personalized nutrition, coaching, and community. Discover the future of weight management.
London's Arctic Chill Eases, Rain and Normal Temps Ahead
The deep freeze in London, Ontario, is finally relenting. CTV meteorologist Julie Atchison forecasts a shift to near-seasonal temperatures and rain, ending the prolonged Arctic chill.
Hims & Hers Acquires Livewell for Canadian Expansion
U.S. telehealth giant Hims & Hers acquires Canadian platform Livewell, positioning itself to launch generic semaglutide (Ozempic) in Canada as Novo Nordisk's patent lapses. The move targets a market where two-thirds of adults face weight-related health ch
Novo Nordisk to test obesity drug CagriSema in children
Novo Nordisk, maker of Wegovy, plans clinical trials for its experimental obesity medication CagriSema in overweight children and adolescents. Get the latest details on this significant development in pediatric health.
Trump's Preventative MRI Shows Normal Heart, Abdomen Results
Former U.S. President Donald Trump underwent a preventative MRI scan, with his doctor confirming 'perfectly normal' results for his heart and abdomen. Details on the routine check-up.
Belly Fat Linked to Dangerous Heart Changes in Men
New research reveals abdominal fat, particularly in men, is strongly linked to dangerous heart remodelling. Learn the risks and what the data means for Canadians.
WHO Backs GLP-1 Treatments for Obesity Epidemic
The World Health Organization has officially endorsed GLP-1 receptor agonist treatments, including drugs like Ozempic, as a key tool to tackle the global obesity epidemic. Learn what this means for public health.
Eli Lilly cuts price of obesity drug Zepbound
Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.
GLP-1 Drugs Like Ozempic Threaten Fast-Food Business
Experts warn injectable weight-loss drugs such as Ozempic are reducing consumer appetites, posing a significant challenge to the fast-food sector's traditional business model in Canada.
Meet Tanice: Toronto Sun's SUNshine Girl Entrepreneur
Discover Tanice, the Toronto Sun's latest SUNshine Girl - a model and entrepreneur balancing garden maintenance with fitness passions. Learn her inspiring story today!
Novo's obesity drug shows 14.5% weight loss in trial
Novo Nordisk's experimental obesity drug amycretin demonstrates significant weight loss results in mid-stage study, advancing to late-phase testing for diabetes patients.
Above Normal Temperatures Continue in Winnipeg Forecast
Meteorologist Colleen Bready reports continued above-normal temperatures for Winnipeg with mild conditions and sunshine. Get the latest weather updates and forecast details.
Novo Nordisk Alzheimer's Drug Trials Fail
Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.
Eli Lilly Reaches $1 Trillion Valuation Milestone
Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.
Jelly Roll Unrecognizable After 200-Pound Weight Loss Journey
Country superstar Jelly Roll reveals dramatic new look after shaving beard for first time in decade following 200-pound natural weight loss transformation.
Ozempic Reshapes Canada's Food Economy: $3.3B Impact
Two million Canadians using GLP-1 drugs like Ozempic are dramatically changing food consumption patterns, removing $3.3 billion annually from Canada's food economy. Learn how this trend affects groceries, restaurants and agriculture.
Meghan Trainor responds to skinny-shaming with new song
Meghan Trainor reveals how negative comments about her weight loss inspired her new single 'Still Don't Care.' The singer opens up about her health journey and body image struggles.
Novo Nordisk rolls out $349 Wegovy cash price early
Novo Nordisk introduces $349 cash price for Wegovy weight-loss drug ahead of schedule. Learn how this affects Canadian healthcare access and affordability.
Sydney Sweeney gains 35 pounds for boxing role
Actress Sydney Sweeney discusses her dramatic 35-pound weight gain to portray boxer Christy Martin in a new biopic, while also addressing recent controversies.
Canada's Struggle for Normalcy Amid Teacher Strikes
George Brookman argues Canadians pine for normalcy as teacher strikes and healthcare crises escalate. Discover why ideological debates must end to restore basic standards.
GLP-1 Drugs and Hair Loss: What You Need to Know
Discover why some patients experience hair loss while taking GLP-1 medications like Ozempic. Learn about the science behind this side effect and expert recommendations.
Quebec man extradited for $1.8M weight-loss scam
Supreme Court refuses appeal for Quebec man accused of $1.8 million weight-loss fraud. Extradition to U.S. proceeds in international scam case. Read the full details.
Ozempic Penis: The Truth Behind Viral Claim
Discover the truth about 'Ozempic penis' - the viral claim about GLP-1 medications. Urologists explain why it's an optical illusion and reveal real sexual side effects.
Gordon Ramsay's fiery rejection of weight-loss drug menus
Celebrity chef Gordon Ramsay refuses to create menus for diners on weight-loss drugs like Ozempic, sparking debate. Discover his controversial stance and its potential impact.
Pfizer wins $10B obesity drug takeover battle
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
Trump's Plan to Slash Obesity Drug Prices
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
Trump Reveals Deal to Lower Obesity Drug Costs
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Trump Obesity Drug Deal Boosts Pharma Stocks
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Page 1 of 2